









Markets
/
Stocks
/
nasdaq-maze
/

Maze Therapeutics Inc

MAZE

42.100USD

+0.020+0.05%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

2.02BMarket Cap

LossP/E TTM



Maze Therapeutics Inc

42.100

+0.020+0.05%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Maze Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2023Q4

FY2023Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-6.19%-24.64M

---30.05M

---29.52M

-8.76%-22.45M

-16.19%-23.20M

---20.64M

---19.97M

Net income from continuing operations

-21.55%-30.09M

---33.68M

---32.79M

-11.30%-29.58M

-0.02%-24.75M

---26.58M

---24.75M

Operating gains losses

-27.54%571.00K

--649.00K

--684.00K

-27.77%705.00K

-21.51%788.00K

--976.00K

--1.00M

Other non-cash items

-49.10%509.00K

--779.00K

--785.00K

9.40%896.00K

43.88%1.00M

--819.00K

--695.00K

Change in working capital

109.58%501.00K

---1.04M

---1.43M

145.86%1.03M

-643.30%-5.23M

---2.25M

--963.00K

-Change in prepaid expenses

-4953.33%-758.00K

---1.28M

---474.00K

59.20%-510.00K

-101.68%-15.00K

---1.25M

--894.00K

-Change in other current assets

121.92%356.00K

---320.00K

--338.00K

36.28%-339.00K

-1251.77%-1.62M

---532.00K

--141.00K

Cash from non-recurring investing activities

Cash from operating activities

-6.19%-24.64M

---30.05M

---29.52M

-8.76%-22.45M

-16.19%-23.20M

---20.64M

---19.97M

Investing cash flow

Net cash from continuing investing activities

-33.98%68.00K

--393.00K

--299.00K

1679.41%605.00K

3533.33%103.00K

--34.00K

---3.00K

Capital expenditures

-33.98%68.00K

--393.00K

--299.00K

1679.41%605.00K

--103.00K

--34.00K

----

Net cash flow from disposal of fixed assets

-33.98%68.00K

--393.00K

--299.00K

1679.41%605.00K

3533.33%103.00K

--34.00K

---3.00K

Net cash flow from investment products

---66.81M

----

Cash from non-current investing activities

Net cash flow from investing activities

-64834.95%-66.88M

---393.00K

---299.00K

-1679.41%-605.00K

-3533.33%-103.00K

---34.00K

--3.00K

Financing cash flow

Cash flow from continuous financing activities

6786.37%143.76M

--612.00K

--127.38M

334.04%70.26M

-26975.00%-2.15M

--16.19M

--8.00K

Net cash flow from debt Issuance/repayment

----

-100.00%0.00

--0.00

--16.18M

--0.00

Net cash flow from common stock issuance/repurchase

--0.00

--612.00K

--127.75M

----

Net cash flow from preferred stock issuance/repurchase

----

--70.79M

----

Proceeds from stock option exercised by employees

788.94%2.01M

--0.00

--126.00K

425.00%63.00K

2725.00%226.00K

--12.00K

--8.00K

Net cash flow from other financing activities

6065.82%141.75M

--0.00

---500.00K

---594.00K

---2.38M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

6786.37%143.76M

--612.00K

--127.38M

334.04%70.26M

-26975.00%-2.15M

--16.19M

--8.00K

Net cash flow

Beginning cash balance

50.80%265.63M

--295.46M

--197.90M

333.84%150.69M

222.06%176.15M

--34.73M

--54.70M

Current period cash flow changes

305.17%52.23M

---29.83M

--97.56M

1151.57%47.20M

-27.54%-25.46M

---4.49M

---19.96M

Ending cash balance

110.93%317.86M

--265.63M

--295.46M

554.30%197.90M

333.84%150.69M

--30.25M

--34.73M

Free cash flow

-6.02%-24.71M

---30.45M

---29.82M

-11.51%-23.06M

-16.70%-23.31M

---20.68M

---19.97M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

